Observational studyFrontiers in public health2023

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer.

Shanshan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.